5,102
Views
244
CrossRef citations to date
0
Altmetric
Articles

An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health

&

References

  • AACR. (2011). American Association for Cancer Research's 102nd Annual Meeting (held Saturday, April 2 - Wednesday, April 6, 2011) at the Orange County Convention Center in Orlando, Florida.
  • Adjakly, M., Ngollo, M., Lebert, A., Dagdemir, A., Penault-Llorca, F., Boiteux, J. P., Bignon, Y. J., Guy, L. and Bernard-Gallon, D. (2014). Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines. Nutr. Cancer 66:474–482.
  • Aguiar, C. L. (2010). Effects of the Processing Techniques on Isoflavone Profiles: A review. In: Isoflavones: Biosynthesis, occurrence and health effects. pp. 225–237. Melanie J Thompson, Ed., Nova Publishers, USA.
  • Ahn-Jarvis, J. H., Riedl, K. M., Schwartz, S. J. and Vodovotz, Y. (2013). Design and selection of soy breads used for evaluating isoflavone bioavailability in clinical trials. J. Agric. Food Chem. 61:3111–3120.
  • Akaza, H. (2012). Prostate cancer chemoprevention by soy isoflavones: Role of intestinal bacteria as “second genome”. Cancer Sci. 103:969–975.
  • Akhtar, M. H., Reid, C. and Bryan, M. (2002). Isoflavone contents in fifty soybean varieties grown in Canada. 5th AAFC Food Network meeting, Kentville, NS. June 18–20, Abs. No. 36.
  • Alekel, D. L., Van Loan, M. D., Koehler, K. J., Hanson, L. N., Stewart, J. W., Hanson, K. B., Kurzer, M. S. and Peterson, C. T. (2010). The soy isoflavones for reducing bone loss (SIRBL) study: A 3-y randomized controlled trial in postmenopausal women. Am. J. Clin. Nutr. 91:218–230.
  • Alezandro, M. R., Granato, D., Lajolo, F. M. and Genovese, M. I. (2011). Nutritional aspects of second generation soy foods. J. Agric. Food. Chem. 59:5490–5497.
  • Anderson, J. W., Johnstone, B. M. and Cook-Newell, M. E. (1995). Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333:276–282.
  • Andres, A., Donovan, S. M. and Kuhlenschmidt, M. S. (2009). Soy isoflavones and virus infections. J. Nutr. Biochem. 20:563–569.
  • ANVISA. (2003). Guia para validação de métodos analíticos e bioanalíticos, Resolução no. 899 de 29 de maio de 2003. Agência Nacional de Vigilância Sanitária, Ministério da Saúde.
  • Astuti, M. and Dalais, F. S. (2000). Tempeh, a nutritious and health food from Indonesia. Asia Pacific J. Clin. Nutr. 9:322–325.
  • Auwerter, L. C. C., Wanczinski, A. E. and Chiandotti, R. S. (2012). Development of an analytical method to quantify total isoflavones in phytotherapic capsules using high-performance liquid chromatography. Rev. Bras. Farmacogn. 22.
  • Badger, T. M., Gilchrist, J. M., Pivik, R. T., Andres, A., Shankar, K., Chen, J. and Ronis, M. J. (2009). The health implications of soy infant formula. Am J Clin. Nutr. 89:1668S–1672S.
  • Baiano, A. (2010). Effects of Processing on Isoflavone Content and Profile in Foodstuffs: A Review. In: Isoflavones: Biosynthesis, occurrence and health effects. pp. 111–135. Melanie J Thompson, Ed., Nova Publishers, USA.
  • Barnes, S. (2010). The Biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat. Res. Biol. 8:89–98.
  • Barnes, S., Wang, C. C., Kirk, M., Smith-Johnson, M., Coward, L., Barnes, N. C., Vance, G. and Boersma, B. (2002). HPLC-mass spectrometry of isoflavonoids in soy and the American groundnut, Apios americana. Adv. Exp. Med. Biol. 505:77–88.
  • Bhatia, J., Greer, F. and the Committee on Nutrition, American Academy of Pediatrics. (2009). Soy protein-based formulas: Recommendations for Use in infant feeding. Pediatrics 101:1062–1068.
  • Casini, M. L., Marelli, G. and Papaleo, E., Ferrari, A., D'Ambrosio, F. and Unfer, V. (2006). Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: A randomized double-blind, crossover, placebo-controlled study. Fertil. Steril. 85:972–978.
  • Cassidy, A., Brown, J. E., Hawdon, A., Faughnan, M. S., King, L. J., Millward, J., Zimmer-Nechemias, L., Wolfe, B. and Setchell, K. D. (2006). Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nutr. 136:45–51.
  • Cederroth, C. R., Zimmermann, C. and Nef, S. (2012). Soy, phytoestrogens and their impact on reproductive health. Mol. Cell. Endocrinol. 355:192–200.
  • Chan, C., Qi, X., Li, M. W., Wong, F. L. and Lam, H. M. (2012). Recent Developments of Genomic Research in Soybean. J. Genet. Genomics 39:317–324.
  • Chen, M. N., Lin, C. C. and Liu, C. (2014). Efficacy of phytoestrogens for menopausal symptoms: A meta-analysis and systematic review. Climacteric 1–21. [Epub ahead of print]
  • Chen, T. R. and Wei, Q. K. (2008). Analysis of bioactive aglycone isoflavones in soybean and soybean products. Nutr. Food Sci. 38:540–547.
  • Chien, H. L., Huang, H. Y. and Chou, C. C. (2006). Transformation of isoflavone phytoestrogens during the fermentation of soymilk with lactic acid bacteria and bifidobacteria. Food Microbiol. 23:772–778.
  • Clarkson, T. B. (2000). Soy phytoestrogens: What will be their role in postmenopausal hormone replacement therapy? Menopause 7: 71–75.
  • Clarkson, T. B., Utian, W. H., Allmen, T. I., Aso, T., Barnes, S., Basaria, S. S. and Brinton, B. D. (2011). The role of soy isoflavones in menopausal health: Report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause 18:732–753.
  • Collison, M. W. (2008). Determination of Total Soy Isoflavones in Dietary Supplements, Supplement Ingredients, and Soy Foods by High-Performance Liquid Chromatography with Ultraviolet Detection: Collaborative Study. J. AOAC Int. 91:489–500.
  • Coward, L., Smith, M., Kirk, M. and Barnes, S. (1998). Chemical modification of isoflavones in soy foods during cooking and processing. Am. J. Clin. Nutr. 68:1486S–1491S.
  • Curtis, P. J., Sampson, M., Potter, J., Dhatariya, K., Kroon, P. A. and Cassidy, A. (2012). Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-Year CVD risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized, controlled trial. Diabetes Care 35:226–232.
  • Dagdemir, A., Durif, J., Ngollo, M., Bignon, Y. J. and Bernard-Gallon, D. (2013a). Breast Cancer: Mechanisms Involved in Action of Phytoestrogens and Epigenetic Changes. In Vivo 27:1–9.
  • Dagdemir, A., Durif, J., Ngollo, M., Bignon, Y. J. and Bernard- Gallon, D. (2013b). Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. Epigenomics 5:51–63.
  • Dalais, F. S., Meliala, A., Wattanapenpaiboon, N., Frydenberg, M., Suter, D. A., Thomson, W. K. and Wahlqvist, M. L. (2004). Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urol. 64:510–515.
  • Davis, T. A., Mungunsukh, O., Zins, S., Day, R. M. and Landauer, M. R. (2008). Genistein induces radioprotection by hematopoietic stem cell quiescence. Int. J. Radiat. Biol. 84:713–726.
  • Deshmukh, K. A. and Amin, P. D. (2012). Stability Indicating RP-HPLC Method for Analysis of Soy Isoflavones in Pharmaceutical Formulations. Analyt. Chem. Lett. 2:327–336.
  • De Souza, P. L., Russell, P. J., Kearsley, J. H. and Howes, L. G. (2010). Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. Nutr. Rev. 68:542–555.
  • Devi, M. K., Gondi, M., Sakthivelu, G., Girdhar, P., Rajasekaran, T. and Ravishankar, G. A. (2009). Functional attributes of soybean seeds and products with reference to isoflavone content and antioxidant activity. Food Chem. 114:771–776.
  • Dhaobhadel, S. (2011). Regulation of Isoflavonoid Biosynthesis in Soybean Seeds. In: Biochemistry, Chemistry and Physiology. pp. 244–258. Prof. Tzi-Bun Ng., Ed., In Tech, Europe.
  • Dixit, A. K., Bhatnagar, D., Kumar, V., Rani, A., Manjaya, J. G. and Bhatnagar, D. (2010). Gamma irradiation induced enhancement in isoflavones, total phenol, anthocyanin and antioxidant properties of varying seed coat colored soybean. J. Agric. Food Chem. 58:4298–4302.
  • Djuric, Z., Chen, G., Doerge, D. R., Heilbrun, L. K. and Kucuk, O. (2001). Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett. 172:1–6.
  • D'Adamo, C. R. and Sahin, A. (2014). Soy foods and supplementation: A review of commonly perceived health benefits and risks. Altern. Ther. Health Med. 20:39–51.
  • EEC Regulations. (1987). No. 1898/87 dated July 02, 1987 on the protection of designations used in marketing of milk and milk products (accessed August 02, 2013) http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri = CELEX:32006R1628:en:NOT
  • Eisen, B., Unger, Y. and Shimoni, E. (2003). Stability of isoflavones in soymilk stored at elevated and ambient temperatures. J. Agric. Food Chem. 51:2212–2215.
  • Ferreira, M. P., Oliveira, M. C. N., Mandarino, J. M. G., Silva, J. B., Ida, E. I. and Carrão-Panizzi, M. C. (2011). Changes in the isoflavone profile and in the chemical composition of tempeh during processing and refrigeration. Pesquisa Agropecuária Brasileira 46:1555–1561.
  • Ganry, O. (2005). Phytoestrogens and prostate cancer risk. Prev. Med. 41:1–6.
  • González Cañete, N. and Durán Agüero, S. (2014). Soy isoflavones and evidences on cardiovascular protection. Nutr. Hosp. 29:1271–1282.
  • Greendale, G. A., Huang, M. H., Leung, K., Crawford, S., Gold, E. B., Wight, R., Waetjen, E. and Karlamangla, A. S. (2012). Dietary phytoestrogen intakes and cognitive function during the menopause transition: Results from the SWAN Phytoestrogen Study. Menopause 19:894–903.
  • Hamilton-Reeves, J. M., Banerjee, S., Banerjee, S. K., Holzbeierlein, J. M., Thrasher, J. B., Kambhampati, S., Keighley, J. and Van Veldhuizen, P. (2013). Short-Term Soy Isoflavone Intervention in Patients with Localized Prostate Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. PLoS One 8:e68331. doi: 10.1371/journal.pone.0068331. Print 2013.
  • Hamilton-Reeves, J. M., Vazquez, G., Duval, S. J., Phipps, W. R., Kurzer, M. S. and Messina, M. J. (2010). Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: Results of a meta-analysis. Fertil. Steril. 94:997–1007.
  • Haron, H., Ismail, A., Azlan, A., Shahar, L. S. and Peng, L. S. (2009). Daidzein and genestein contents in tempeh and selected soy products. Food Chem. 115:1350–1356.
  • Henderson, V. W., Paganinin-Hill, A., Miller, B. L., Elble, R. J., Reyes, P. F., Shoupe, D., McCleary, C. A., Klein, R. A., Hake, A. M. and Farlow, M. R. (2000). Estrogen for Alzheimer disease in women, randomized, double-blind placebo-controlled trial. Neurology 54:295–301.
  • Henderson, V. W., St-John, J. A., Hodis, H. N., Kono, N., McCleary, C. A., Franke, A. A. and Mack, W. J. (2012). Long-term soy isoflavone supplementation and cognition in women- a randomized, controlled trial. Neurology 78:1841–1848.
  • Hiroshi, E., Masahiro, O., Katsuo, T., Shinji, S. and Kentaro, K. (2003). Effect of variety of soybean seed and processing of soy milk on the isoflavone content of tofu. Food Preserv. Sci. 29:165–172.
  • Ho, H., Chen, R., Leung, L., Chan, F., Huang, Y. and Chen, Z. (2002). Difference in flavonoid and isoflavone profile between soybean and soy leaf. Biomed. Pharmacother 56:289–295.
  • Hong, G. E., Mandal, P. K., Lim, K. W. and Lee-H, C. (2012). Fermentation increases isoflavone aglycone contents in black soybean pulp. Asian J. Animal Vet. Advances 6:502–511.
  • Ichige, M., Fukuda, E., Miida, S., Hattan, J. I., Misawa, N., Saito, S., Fujimaki, T., Imoto, M. and Shindo, K. (2013). Novel Isoflavone Glucosides in Groundnut (Apios americana Medik) and Their Antiandrogenic Activities. J. Agric. Food Chem. 61:2183–2187.
  • Jackson, C. J. C., Dini, J. P., Lavandier, C., Rupasinghe, H. P. V., Faulkner, H., Poysa, V., Buzzell, D. and DeGrandis, S. (2002). Effects of processing on the content and composition of isoflavones during manufacturing of soy beverage and tofu. Process Biochem. 37:1117–1123.
  • Jenks, B. H., Iwashita, S., Nakagawa, Y., Ragland, K., Lee, J., Carson, W. H., Ueno, T. and Uchiyama, S. (2012). A Pilot Study on the effects of S-Equol compared to soy isoflavones on menopausal hot flash frequency. J. Women's Health (Larchmt) 21:674–692.
  • Jiao, Z., Si, X., Zhang, Z. M., Li, G. K. and Cai, Z. W. (2012). Compositional study of different soybean (Glycine max L.) varieties by 1H NMR spectroscopy, chromatographic and spectrometric techniques. Food Chem. 135:285–291.
  • Kano, M., Takayanagi, T., Harada, K., Sawada, S. and Ishikawa, F. (2006). Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J. Nutr. 136:2291–2296.
  • Karr, S. C., Lampe, J. W., Hutchins, A. M. and Slavin, J. L. (1997). Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am. J. Clin. Nutr. 66:46–51.
  • King, R. A. and Bursill, D. B. (1998). Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. 67:867–872.
  • Kozłowska, A. and Szostak-Wegierek, D. (2014). Flavonoids-food sources and health benefits. Rocz. Panstw. Zakl. Hig. 65:79–85.
  • Kuriyama, I., Yoshida, H., Mizushina, Y. and Takahashi, Y. (2013). Inhibitory Effect of Isoflavones from Processed Soybeans on Human DNA Topoisomerase II Activity. J. Plant Biochem. Physiol. 1:106.
  • Kwok, K-C. and Niranjan, K. (1995). Review: Effect of thermal processing on soy milk. Int. J. Food Sci. Tech. 30:263–295.
  • Lee, J. H. and Cho, K. M. (2012). Changes occurring in compositional components of black soybeans maintained at room temperature for different storage periods. Food Chem. 131:161–169.
  • Li, L., Lv, Y., Xu L. and Zheng, Q. (2014). Quantitative efficacy of soy isoflavones on menopausal hot flashes. Br. J. Clin. Pharmacol. 2014 Oct 15. doi: 10.1111/bcp.12533. [Epub ahead of print]
  • Loibl, S., Lintermans, A., Dieudonné, A. and Neven, P. (2011). Management of menopausal symptoms in breast cancer patients. Maturitas 68:148–154.
  • Lozovaya, V. V., Lygin, A. V., Ulanov, A. V., Nelson, R. L., Dayde, J. and Widholm, J. M. (2005). Effect of temperature and soil moisture status during seed development on soybean seed isoflavone concentration and composition. Crop Sci. 45:1934–1940.
  • Magee, P. J., Mcglynn, H. and Rowland, I. R. (2004). Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett. 208:35–41.
  • Mahmoud, A. M., Yang, W. and Bosland, M. C. (2014). Soy isoflavones and prostate cancer: A review of molecular mechanisms. J. Steroid Biochem. Mol. Biol. 140:116–132.
  • Mansouri-Attia, N., James, R., Ligon, A., Li, X. and Pangas, S. A. (2014). Soy promotes juvenile granulosa cell tumor development in mice and in the human granulosa cell tumor-derived COV 434 cell line. Biol Reprod. 91:100. doi: 10.1095/biolreprod.114.120899. Epub 2014 Aug 27.
  • Ma, D. F., Qin, L. Q, Wang, P. Y. and Katoh, R. (2008). Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: Meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 62:155–161.
  • Mazur, W. M., Duke, J. A., Wahala, K., Rasku, S. and Adlercreutz, H. (1998). Isoflavones and lignans in legumes: Nutritional and health aspects in human. J. Nutr. Biochem. 9:193–200.
  • Merz-Demlow, B. E., Duncan, A. M., Wangen, K. E., Xu, X., Carr, T. P., Phipps, W. R. and Kurzer, M. S. (2000). Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 71:1462–1469.
  • Messina, M. (1998). Soy foods: An Alternative to Hormone Replacement Therapy. Vegetarian Nutrition and Health Letter 1(5).
  • Messina, M. (2014). Soy Foods, isoflavones, and the health of postmenopausal women. Am. J. Clin. Nutr. 100:423S–430S.
  • Messina, M., Kucuk, O. and Lampe, J. W. (2006). An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels. J. AOAC Int. 89:1121–1134.
  • Ming, L. G., Chen, K. M. and Xian, C. J. (2013). Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J. Cell Physiol. 228:513–521.
  • Miyanaga, N., Akaza, H., Hinotsu, S., Fujioka, T., Naito, S., Namiki, M., Takahashi, S., Hirao, Y., Horie, S., Tsukamoto, T., Mori, M. and Tsuji, H. (2012). Prostate cancer chemoprevention study: An investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen. Cancer Sci. 103:125–130.
  • Mortensen, A., Kulling, S. E., Schwartz, H., Rowland, I., Ruefer, C. E., Rimbach, G., Cassidy, A., Magee, P., Millar, J., Hall, W. L., Kramer Birkved, F., Sorensen, I. K. and Sontag, G. (2009). Analytical and compositional aspects of isoflavones in food and their biological effects. Mol. Nutr. Food Res. 53:S266–S309.
  • Most, J., Goossens, G. H., Jocken, J. W. and Blaak, E. E. (2013). Short-term supplementation with specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects. Int. J. Obes (Lond). doi: 10.1038/ijo.2013.231. [Epub ahead of print]
  • Nagata, C., Mizoue, T., Tanaka, K., Tsuji, I., Tamakoshi, A., Matsuo, K., Wakai, K., Inoue, M., Tsugane, S. and Sasazuki, S. (2014). Soy intake and breast cancer risks: An evaluation based on s systematic review of epidemiologic evidence among the Japanese population. Jpn. J. Clin. Oncol. 44:282–295.
  • Nagata, Y., Sonoda, T., Mori, M., Miyanaga, N., Okumura, K., Goto, K., Naito, S., Fujimoto, K., Hirao, Y., Takahashi, A., Tsukamoto, T. and Akaza, H. (2007). Dietary isoflavones may protect against prostate cancer in Japanese men. J. Nutr. 137:1974–1979.
  • NAMS (The North American Menopause Society). (2011). The role of soy isoflavones in menopausal health: Report of The North American Menopause Society/Wulf H. UtianTranslational Science Symposium in Chicago, IL (October 2010). Menopause 18:732–753.
  • Nara, K., Nihei, K., Ogasawarara, Y., Koga, H. and Yoji Kato, Y. (2011). Novel isoflavone diglycoside in groundnut (Apios americana Medik). Food Chem. 124:703–710.
  • National Cancer Institute (NCI). (2004). Antioxidants and cancer prevention: Fact sheet. Retrieved November 18, 2008, from http://www.nci.nih.gov/cancertopics/factsheet/antioxidantsprevention.
  • National Soybean Research Laboratory (NSRL). (2013). http://www.nsrl.uiuc.edu/aboutsoy/images/processing_diagram.gif (accessed July 23, 2013).
  • Neese, S. L., Bandara, S. B., Doerge, D. R., Helferich, W. G., Korol, D. L. and Schantz, S. L. (2012). Effects of multiple daily genistein treatments on delayed alternation and differential reinforcement of low rates of responding task in middle-aged rats. Neurotoxicol. Teratol. 34:187–195.
  • Nielsen, I. L. and Williamson, G. (2007). Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr. Cancer 57:1–10.
  • Oomah, B. D. and Hosseinian, F. S. (2002). Phytoestrogens. In: Methods of Analysis for Functional Foods and Nutraceuticals. pp. 1–63. Hurst, W. J., Ed., CRC Press, Florida.
  • Orgaard, A. and Jensen, L. (2008). The effects of soy isoflavones on obesity. Exp. Biol. Med. 233:1066–1080.
  • Pananun, T., Montalbo-Lomboy, M., Noomhorm, A., Grewell, D. and Lamsal, B. (2012). High-power ultrasonication-assisted extraction of soybean isoflavones and effect of toasting. Food Sci. Tech. 47:1999–2007.
  • Patel, R. P., Boersma, B. J., Crawford, J. H., Hogg, N., Kirk, M., Kalyanaraman, B., Parks, D. A., Barnes, S. and Darley-Usmar, V. (2001). Antioxidant mechanisms of isoflavones in lipid systems: Paradoxical effects of peroxyl radical scavenging. Free Radic. Biol. Med. 31:1570–1581.
  • Patisaul, H. B. and Jefferson, W. (2010). The pros and cons of phytoestrogens. Front. Neuroendocrinol. 31:400–419.
  • Pednekar, M., Das, A. K., Rajalakshmi, V. and Sharma, A. (2010). Radiation processing and functional properties of soybean (Glycine max). Radiat. Phys. Chem. 79:490–494.
  • Pendleton, J. M., Tan, W. W., Anai, S., Chang, M., Hou, W., Shiverick, K. T. and Rosser, C. J. (2008). Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer 8:132.
  • Pinto, M. S., Lajolo, F. M. and Genovese, M. I. (2005). Effect of storage temperature and water activity on the content of profile of isoflavones, antioxidant activity and in vitro protein digestibility of soy protein isolates and defatted soy flours. J. Agric. Food Chem. 53:6340–6346.
  • Popović, B. M., Stajner, D., Mandić, A., Canadanović-Brunet, J. and Kevrešan, S. (2013). Enhancement of antioxidant and isoflavones concentration in gamma irradiated soybean. Scientific World Journal. Nov 5; 2013:383574. doi: 10.1155/2013/383574.
  • Preedy, V. R. (2013). Isoflavones: Chemistry, Analysis, Function and Effects. In: Preedy, V. R., Ed., Royal Society of Chemistry (RSC Publishing), Cambridge, UK.
  • Pudenz, M., Roth, K. and Gerhauser, C. (2014). Impact of soy isoflavones on the epigenome in cancer prevention. Nutrients 6:4218–4272.
  • Pulse Canada. (2013). The health benefits of pulses- Clinical trial findings. http://www.pulsecanada.com/uploads/81/3c/813. (accessed September 22, 2013)
  • Reinli, K. and Block, G. (1996). Phytoestrogen content of foods–a compendium of literature values. Nutr Cancer 26:123–148.
  • Riboli, E., Hunt, K. J., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U. R., Hémon, B., Casagrande, C., Vignat, J., Overvad, K., Tjønneland, A., Clavel-Chapelon, F., Thiébaut, A., Wahrendorf, J., Boeing, H., Trichopoulos, D., Trichopoulou, A., Vineis, P., Palli, D., Bueno-De-Mesquita, H. B., Peeters, P. H., Lund, E., Engeset, D., González, C. A., Barricarte, A., Berglund, G., Hallmans, G., Day, N. E., Key, T. J., Kaaks, R. and Saracci, R. (2002). European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection. Public Health Nutr. 5:1113–1124.
  • Rostagno, M. A., Villares, A., Guillamon, E., García-Lafuente, A. and Martínez, J. A. (2009). Sample preparation for the analysis of isoflavones from soybeans and soy foods. J. Chromatogr A. 1216:2–29.
  • Rowland, I., Faughnan, M., Hoey, L., Wähälä, K., Williamson, G. and Cassidy, A. (2003). Bioavailability of phyto-oestrogens. Br. J. Nutr. 89:S45–S58.
  • Rowland, I., Wiseman, H., Sanders, T., Adlercreutz, H. and Bowey, E. (1999). Metabolism of oestrogens and phytoestrogens: Role of the gut microflora. Biochem. Soc. Trans. 27:304–308.
  • Santhakumar, A. B., Bulmer, A. C. and Singh, I. (2014). A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk. J. Hum. Nutr. Diet. 27:1–21.
  • Santos- Galduroz, R. F., Galduroz, J. C., Facco, R. L., Hachul, H. and Tufik, S. (2010). Effects of isoflavones on the learning and memory of women in menopause: A double-blind placebo-controlled study. Braz. J. Med. Biol. Res. 43:1123–1126.
  • Saracino, M. A., Mercolini, L., Musenga, A., Bugamelli, F. and Raggi, M. A. (2008). Comparison of analytical methods for the quality control of new formulation containing soy extract and melatonin. J. Sep. Sci. 31:1851–1859.
  • Seguin, P., Zheng, W., Smith, D. L. and Deng, W. (2004). Isoflavone content of soybean cultivars grown in eastern Canada. J. Sci. Food Agric. 84:1327–1332.
  • Sertovic, E., Mujic, I., Jokic, S., Alibabic, V. and Saric, Z. (2012). Effect of soybean cultivars and the content of isoflavone on soymilk. Romanian Biotechnol. Lett. 17:7151–7159.
  • Setchell, K. D., Brown, N. M. and Lydeking-Olsen, E. (2002). The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr. 132:3577–3584.
  • Shao, S., Duncan, A. M., Yanga, R., Marcone, M. F., Rajcan, I. and Tsao, R. (2009). Tracking isoflavones: From soybean to soy flour, soy protein isolates to functional soy bread. J. Functional Foods 1:119–127.
  • Siepmann, T., Roofeh, J., Kiefer, F. W. and Edelson, D. G. (2011). Hypogonadism and erectile dysfunction associated with soy product consumption. Nutrition 27:859–862.
  • Silva, L. H., Celeghini, R. M. S. and Chang, Y. K. (2011). Effect of the fermentation of whole soybean flour on the conversion of isoflavones from glycosides to aglycones. Food Chem. 128:640–644.
  • Simmons, A. L., Chitchumroonchokchai, C., Vodovotz, Y. and Failla, M. L. (2012). Isoflavone retention during processing, bioaccessibility, and transport by Caco-2 cells: Effects of source and amount of fat in a soy soft pretzel. J. Agric. Food Chem. 60:12196–12203.
  • Simonne, A. H., Smith, M., Weaver, D. B. and Wei, C. I. (2000). Retention and changes of soy isoflavones and carotenoids in immature soybean seeds (Edamame) during processing. J. Agric. Food Chem. 48:6061–6069.
  • Soukup, S. T., Al-Maharik, N., Botting, N., Kulling, S. E. (2014). Quantification of soy isoflavones and their conjugative metabolites in plasma and urine: An automated and validated UHPLC-MS/MS method for use in large –scale studies. Anal. Bioanal. Chem. 406:6007–6020.
  • Soyatech. (2013). http://soyatech.com/soy_facts.htm, accessed July 22, 2013.
  • Taku, K., Melby, M. K., Kronenberg, F., Kurzer, M. S. and Messina, M. (2012). Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: Systematic review and meta-analysis of randomized controlled trials. Menopause 19:776–790.
  • Taku, K., Melby, M. K., Nishi, N., Omori, T. and Kurzer, M. S. (2011). Soy isoflavones for osteoporosis: An evidence-based approach. Maturitas 70:333–338.
  • Thai, T. Y., Tsai, K. S., Tu, S. T., Wu, J. S., Chang, C. I., Chen, C. L., Shaw, N. S., Peng, H. Y., Wang, S. Y. and Wu, C. H. (2012). The effect of soy isoflavones on bone mineral density in post-menopausal Taiwanese women with bone loss: A 2 year randomized double blind placebo-controlled study. Osteoporos Int. 23:1571–1580.
  • Tham, D., Gardner, C. and Haskell, W. (1998). Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metabol. 83:2223–2235.
  • Thompson, M. J. (2010). Isoflavones: Biosynthesis, Occurrence and Health Effects. Nova Publishers, New York, USA.
  • Thuzar, M., Puteh, A. B., Abdullah, N. A. P., Lassim, M. B. M. and Jusoff, K. (2010). The Effects of Temperature Stress on the Quality and Yield of Soya Bean [(Glycine max L.) Merrill.]. J. Agric. Sci. 2:172–179.
  • United States Department of Agriculture (USDA). (2012). World Agricultural Supply and Demand Estimates: WASDE- 504 (ISSN: 1554–9089). www.usda.gov/oce/commodity/wasde/latest.pdf
  • USDA. (2002). Iowa State University Isoflavones Database. United States Department of Agriculture [Web page]. March 15, 2002.Available at: http://www.nal.usda.gov/fnic/foodcomp/Data/isoflav/isoflav.html.
  • USDA. (2008). USDA National Nutrient Database http://www.ars.usda.gov/nutrientdata. Accessed August 20, 2013. Also available at www.isoflavones.info/isoflavones-content.php (accessed August 20, 2013).
  • Uzzan, M., Nechrebeki, J. and Labuza, T. P. (2007). Thermal and storage stability of nutraceuticals in a milk beverage dietary supplement. J. Food Sci. 72:E109–E114.
  • Vandenplas, Y., Castrellon, P. G., Rivas, R., Gutiérrez, C. J., Garcia, L. D., Jimenez, J. E., Anzo, A., Hegar B. and Alarcon, P. (2014). Safety of soya-based infant formulas in children. Br. J. Nutr. 111:1340–1360.
  • van Die, M. D., Bone, K. M., Williams, S. G. and Pirotta, M. V. (2014). Soy and soy isoflavones in prostate cancer: A systematic review and meta-analysis of randomized controlled trials. BJU Int. 113:E119–E130.
  • Velasquez, M. T. and Bhathena, S. J. (2007). Role of dietary soy protein in obesity. Int. J. Med. Sci. 4:72–82.
  • Waggle, D. and Bryan, B. (2000). Recovery of Isoflavones from Soy Molasses. United States Patent 6,083,552.
  • Wang, H. J. and Murphy, P. A. (1994). Isoflavone composition of American and Japanese Soybeans in Iowa- Effects of variety, crop year, and location. J. Agric. Food Chem. 42:1674–1677.
  • Wei, H., Bowen, R., Cai, Q., Barnes, S. and Wang, Y. (1995). Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 208:124–130.
  • Wei, P., Liu, M., Chen, Y. and Chen, D. C. (2012). Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac. J. Trop. Med. 5:243–248.
  • World Statistics. (2013). http://soybeans.com/2012/page_30.htm accessed July 22, 2013.
  • Wrenn, C. C. (2013). Dietary isoflavones and learning and memory. In: Isoflavones: Chemistry, Analysis, Function and Effects. pp. 451–464. Preedy, V. R., Ed., Royal Society of Chemistry (RSC publishing), UK.
  • Xu, B. and Chang, S. K. (2008). Total phenolics, phenolic acids, isoflavones, and anthocyanins and antioxidant properties of yellow and black soybeans as affected by thermal processing. J. Agric. Food Chem. 56:7165–7175.
  • Yang, S. O., Chang, P. S. and Lee, J. H. (2006). Isoflavone distribution and beta-glucosidase activity in Cheonggukjang, a traditional Korean whole soybean-fermented food. Food Sci. Biotech. 15:96–101.
  • Yan, L. and Spitznagel, E. L. (2009). Soy consumption and prostate cancer risk in men: A revisit of a meta-analysis. Am. J. Clin. Nutr. 89:1155–1163.
  • Yin, D., Zhu, Y., Liu, L., Xu, H., Huang, J. and Li, Y. (2014). Potential detrimental effect of soy isoflavones on testis sertoli cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 39:598–604.
  • Zamora-Ros, R., Knaze, V., Luján-Barroso, L., Kuhnle, G. G., Mulligan, A. A., Touillaud, M., Slimani, N., Romieu, I,., Powell, N., Tumino, R., Peeters, P. H., de Magistris, M. S., Ricceri, F., Sonestedt, E., Drake, I,., Hjartåker, A., Skie, G., Mouw, T., Wark, P. A., Romaguera, D., Bueno-de-Mesquita, H. B., Ros, M., Molina, E., Sieri, S., Quirós, J. R., Huerta, J. M., Tjønneland, A., Halkjær, J., Masala, G., Teucher, B., Kaas, R., Travis, R. C., Dilis, V., Benetou, V., Trichopoulou, A., Amiano, P., Ardanaz, E., Boeing, H., Förster, J., Clavel-Chapelon, F., Fagherazzi, G., Perquier, F., Johansson, G., Johansson, I,., Cassidy, A., Overvad, K. and González, C. A. (2012). Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort. Eur. J. Clin. Nutr. 66:932–941.
  • Zhang, X., Gao, Y. T., Yang, G., Li, H., Cai, Q., Xiang, Y. B., Ji, B. T., Franke, A. A., Zheng, W. and Shu, X. O. (2012). Urinary isoflavonoids and risk of coronary heart disease. Int. J. Epidemiol. 41:1367–1375.
  • Zheng, G. and Zhu, S. (1999). Antioxidant effects of soybean isoflavones. In: Antioxidants in Human Health. pp. 123–130. Basu, T. K., Temple, N. J. and Garg, M. L., Eds., CAB Publishing, Oxon, UK.
  • Zimmermann, C., Cederroth, C. R., Bourgoin, L., Foti, M. and Nef. S. (2012). Prevention of diabetes in db/db mice by dietary soy is independent of isoflavone levels. Endocrinol. 153:5200–5211.
  • Zuniga, K. E., Clinton, S. K. and Erdman, J. W. Jr. (2013). The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model. Cancer Prev. Res. 6:548–557.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.